Bronchogen 20 mg

Steroids Dragon Pharma Peptides

$70.00

Dragon Pharma Bronchogen 20 mg – Synthetic Tetrapeptide for Respiratory Research

✔ Synthetic AEDL tetrapeptide bioregulator ✔ Khavinson peptide class compound ✔ Studied for lung tissue regeneration ✔ USA domestic shipping available

Dragon Pharma Bronchogen 20 mg is a synthetic tetrapeptide bioregulator with the amino acid sequence Ala-Glu-Asp-Leu (AEDL). As part of the well-characterized Khavinson peptide group, this compound has been the subject of experimental research focusing on lung tissue regeneration, DNA stabilization, and anti-inflammatory effects in respiratory models.

Each vial contains 20 mg of lyophilized Bronchogen in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Bronchogen represents a targeted approach to studying pulmonary tissue repair mechanisms and the molecular pathways underlying respiratory health. For related research compounds, explore our peptides category and specifically SS-31 50 mg for mitochondrial function studies.

What Makes Bronchogen Valuable in Research?

Bronchogen belongs to a class of short-chain peptides known for their bioregulatory properties. The AEDL sequence has been investigated for its ability to influence gene expression patterns associated with tissue-specific repair mechanisms. In preclinical respiratory models, Bronchogen has demonstrated potential for supporting cellular regeneration and modulating inflammatory responses.

Researchers value Bronchogen for its targeted approach to pulmonary research. Its short sequence and defined mechanism of action make it a practical tool for investigating the molecular basis of lung tissue homeostasis and repair. For investigators exploring broader peptide-based interventions, Thymosin Alpha-1 offers complementary research avenues in immune modulation.

Current scientific literature on Khavinson peptides, including Bronchogen, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications.

Key Research Applications for Dragon Pharma Bronchogen

✔ Investigation of lung tissue regeneration mechanisms
✔ Evaluation of DNA stabilization in pulmonary cells
✔ Research on anti-inflammatory pathways in respiratory models
✔ Studies of peptide bioregulation in tissue repair
✔ Preclinical models of respiratory health and recovery

For Research Purposes Only

Bronchogen 20 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on regenerative peptides, BPC 157 represents another avenue for investigating tissue healing mechanisms.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:

Steroids

Brand: Dragon Pharma

Manufacturer: Dragon Pharma

Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage & Usage Guidelines</h2> <div class="info-card warning"> <p><strong>For research and laboratory use only.</strong> Dragon Pharma Bronchogen 20 mg is a synthetic tetrapeptide bioregulator. Proper reconstitution, handling, and experimental design are essential for obtaining reliable data.</p> </div> <h3>Reconstitution Protocol</h3> <ul class="usage-highlights"> <li>✔ Use sterile bacteriostatic water for injection</li> <li>✔ Add appropriate volume to achieve desired concentration</li> <li>✔ Swirl gently to dissolve – do not shake vigorously</li> <li>✔ Store reconstituted solution at 2–8°C</li> </ul> <p>Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 20 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.</p> <h3>Typical Research Parameters</h3> <p>In research settings, Bronchogen is typically administered via subcutaneous or intraperitoneal injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.</p> <ul> <li>✔ Commonly used in pulmonary tissue regeneration studies</li> <li>✔ Often combined with histological and molecular analysis</li> <li>✔ Used to investigate DNA stabilization and gene expression</li> <li>✔ Research models include respiratory inflammation and repair</li> </ul> <h3>Factors to Consider in Research Protocols</h3> <ul> <li>Short-chain peptide with specific bioregulatory properties</li> <li>Reconstitution stability is limited; prepare fresh solutions for each use</li> <li>Individual variation in response may be observed across subjects</li> <li>Storage conditions significantly impact peptide stability</li> </ul> <div class="info-card"> <p><strong>Research note:</strong> Bronchogen is part of the Khavinson peptide class, known for their tissue-specific bioregulatory effects. Its short AEDL sequence provides a defined molecular tool for investigating pulmonary repair mechanisms and cellular regeneration pathways.</p> </div> </section> </div>

Reviews:

(0 customer reviews)